• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN UNK SERI SURGICAL SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN UNK SERI SURGICAL SCAFFOLD Back to Search Results
Catalog Number UNK SERI SURGICAL SCAFFOLD
Device Problems Material Disintegration (1177); Patient-Device Incompatibility (2682)
Patient Problems Erythema (1840); Necrosis (1971)
Event Date 11/05/2013
Event Type  Injury  
Event Description
Company rep reported seri was implanted during reconstructive surgery with a concomitant unk breast implant, following which one week after implantation, "the flap overlying the seri became increasingly red with vascular dilatation".Initial symptoms were treated with antibiotics, however "at 8 weeks, the inferior flap thinned to the point of full thickness erosion - exposing the underlying seri.The wound closure remained intact - the breakdown was in the center of the flap".During explant surgery of seri and breast implant, "seri was found to be fully nonadherent to the flap except where suture had been placed.There was no collection/purulent fluid or evidence of infection" or fever.Physician cannot confirm the events as being device related and questions whether they are related to either the user of betadine pre-implantation or the result of "a mechanical erosion related to a thin irradiated flap -as the skin breakdown did not occur at the wound closure but in the center of the inferior flap".Seri was explanted and replaced.
 
Manufacturer Narrative
Further info from the reporter regarding the event and product details has been requested.No add'l info is available at this time.The physician discarded the device when it was explanted and it is no longer available for return.Therefore, allergan will not receive it and no analysis or testing will be done.The events of necrosis, exposure, erythema, and non adherence are surgical/physiological complications and analysis of the device generally does not assist allergan is determining a probable cause for these events.Device labeling addresses the reported event of exposure (impending extrusion) as follows: 'adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK SERI SURGICAL SCAFFOLD
Manufacturer (Section D)
ALLERGAN
medford MA
Manufacturer (Section G)
MEDFORD
200 boston avenue
medford MA 02155
Manufacturer Contact
karen herrera
71 s. los carneros rd
goleta, CA 93117
8059615405
MDR Report Key3677310
MDR Text Key4256689
Report Number3008374097-2014-00013
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Not Applicable
Type of Report Initial
Report Date 02/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SERI SURGICAL SCAFFOLD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/06/2014
Initial Date FDA Received03/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
IMPLANTED:; IMPLANTED WITH CONCOMITANT UNK BREAST IMPLANT; EXPLANTED:
Patient Outcome(s) Required Intervention;
Patient Age34 YR
-
-